Abstract
Introduction and hypothesis
We aimed to compare perioperative complications for women who underwent colpocleisis with and without concomitant hysterectomy, and report the rate of concomitant hysterectomy.
Methods
We conducted a retrospective study using the Healthcare Cost and Utilization Project (HCUP) – Nationwide Inpatient Sample 2004 to 2014. We used International Classification of Diseases, Ninth Revision (ICD-9) codes to identify women with pelvic organ prolapse (POP) who underwent colpocleisis with or without concomitant hysterectomy. Trend over time of each procedure type was created. We calculated odds ratios (ORs) to determine the risk of perioperative complications with or without concomitant hysterectomy. ORs were adjusted for age, race, income, insurance plan, and hypertension.
Results
Of 253,100 adult women who underwent POP repair, 7,431 had colpocleisis. Colpocleisis with concomitant hysterectomy was performed in 1,656 (22.2%) and 5,775 (77.7%) underwent colpocleisis alone (2,469 [33.2%] had a previous hysterectomy). Hysterectomy rates among women with POP undergoing colpocleisis remained relatively steady, whereas those undergoing colpocleisis without hysterectomy declined over time. Prevalence of any complications was higher among those with concomitant hysterectomy (11.4% vs 9.5%, p=0.023). Adjusted OR showed that concomitant hysterectomy increased the risk of complications (OR 1.93, 95% CI 1.45–2.57, p<0.001).
Conclusions
Our large administrative data analysis suggests an increased risk of complications when performing a hysterectomy at the time of colpocleisis. A concomitant hysterectomy was performed in 22% of cases. Whether or not to include hysterectomy at the time of colpocleisis is based on shared decision making, influenced by individual patients’ values, comorbidities, and risk of complications.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Colpocleisis procedures have been performed since the 1800s [1]. These obliterative procedures are typically reserved for advanced stage pelvic organ prolapse (POP), in older individuals no longer wishing to be sexually active through penetrative intercourse. Most women undergoing colpocleisis are reportedly between 60 and 90 years old [2, 3]. Heterogenous data report the comparative rates of:
-
1.
Partial colpocleisis with uterus in situ (LeFort colpocleisis; 18–87%) [3,4,5]
-
2.
Complete colpocleisis in individuals with previous hysterectomy (55–70%) [4, 5]
-
3.
Complete colpocleisis with concomitant hysterectomy (4–27%) [3,4,5]
As a group, colpocleisis procedures are associated with high success rates, ranging from 91 to 100%, as well as low complication rates (6–15%) [1, 3, 4, 6, 7]. Postoperative regret due to loss of coital function has been reported, with a prevalence between 0 and 9% [1, 8]. This reinforces the need for thorough pre-operative counselling to ensure appropriate patient expectations postoperatively. As noted by Hill et al., there is little literature on the difference in outcomes after colpocleisis with concomitant vaginal hysterectomy compared with LeFort colpocleisis [4]. Concomitant hysterectomy is associated with longer operative time and increased mean blood loss, with conflicting evidence regarding impact on transfusion rates in smaller studies [4, 9, 10]. The largest reported series of patients with colpocleisis (N=4,776) did not evaluate the role of concomitant hysterectomy, but found an overall complication rate of 6.82% [6]. In a review of 1,000 cases through the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database, vaginal hysterectomy was associated with an increased risk of serious medical complications (overall 1.2%, 12 serious medical complications in the whole cohort) [3].
We aimed to compare the impact on complication rates of three different approaches to colpocleisis for POP (LeFort with uterus in situ, complete colpocleisis in individuals with previous hysterectomy, and complete colpocleisis with concomitant hysterectomy) among a large study population, through an analysis of the Healthcare Cost and Utilization Project (HCUP) – Nationwide Inpatient Sample database.
Materials and methods
Study samples and selection criteria
We conducted a retrospective study using the HCUP–NIS from 2004 to 2014. HCUP represents a 20% stratified sample of discharge data from hospitals in the USA. Over 7 million hospital stays are represented in this database. Information does not include long-term or rehabilitation facilities (HCUP, 2019). For our analyses, we extracted all hospital record information based on International Classification of Diseases, Ninth Revision (ICD-9), for women who had POP (diagnostic codes: 618.0–618.8) and prolapse repair (procedural codes: 69.2–69.29, 70.4–70.92 excluding 70.72–70.75) with and without hysterectomy (procedural codes 68.3–68.9).
Women who had urogenital and gastrointestinal cancers (179–184, 188–189, 198–199, 152, 197.4–197.8, 209.00–209.03, 209.10–209.17, 209.24–209.27, 209.74, 236) were excluded. Sociodemographic variables of interest included patient age, race, income, medical insurance plan, and length of stay. Comorbidities considered were tobacco smoking (305.1), obesity (278.00, 278.01, 278.03), hypertension (401.0–401.9), diabetes (250.0–250.9), chronic obstructive pulmonary disease (490.00–496.00), coronary artery disease (414.01–414.3), and chronic kidney disease (585.9, 586.00).
Adult women with POP who underwent colpocleisis (procedure codes 70.4 and 70.8) were selected. Two groups were then created composed of women who had undergone colpocleisis with and without hysterectomy. Those who did not have hysterectomy were further divided into women who had a uterine prolapse (LeFort colpocleisis; 618.1 to 618.4) or vaginal vault prolapse (complete colpocleisis; 618.5).
We also extracted common complications associated with colpocleisis, namely hemorrhage including receiving blood transfusion (459.0, 998.11, V58.2) procedure codes 990.0–990.9)), infection, (998.59), bowel obstruction (560.81, 560.89, 560.9), peritoneal abscess (567.22), accidental puncture (998.2), cystotomy (V44.50), injury to the gastrointestinal tract (863.20, 863.29, 863.30, 863.39, 863.40–59,863.80, 863.89, 863.90 and 863.99), wound disruptions (998.30, 998.31, 998.32), venous thromboembolism (453.4x, 453.5x, 453.6, 453.7x, 453.8x, 453.9, 415.1x), cardiovascular complications (410.0–410.9; 398.91, 402.x1, 404.x1, 404.x3, 428.x), pelvic abscess/hematoma (614.4, 665.70), pneumonia (480x, 481, 482. 483.0, 483.8, 485, 486), respiratory complications (997.31. 997.39), genitourinary complications (997.5), C. difficile colitis (008.45), ischemic stroke (362.3x, 433.x1, 434.x1, 436), hemorrhagic stroke (431), and acute kidney injury (584x). A variable called “accidental organ puncture” was created including codes for accidental puncture, cystotomy, and injury to the gastrointestinal tract owing to the low numbers in each category. A variable called “any complications” was created including any of the complications (hemorrhage, requiring transfusion, infection, bowel obstruction, peritoneal abscess, peritonitis, accidental puncture, cystotomy, gastrointestinal injury, wound disruption, deep vein thrombosis or pulmonary embolus, cardiovascular complications, pelvic abscess/pelvic hematoma, pneumonia, respiratory complications, genitourinary complications, C. difficile colitis, ischemic stroke, hemorrhagic stroke, and acute kidney failure. Death was extracted from the variable “Died” in the HCUP database).
Statistical methods
We conducted an evaluation of the prevalence rates for women with POP who had undergone colpocleisis with and without hysterectomy. We also calculated the percentages among women without hysterectomy who had either uterine prolapse or vaginal vault prolapse. Descriptive analysis using baseline sociodemographic characteristics and co-morbidities was performed for women with POP who underwent repair, including those with and those without hysterectomy. Categorical variables are presented as percentages and compared using Chi-squared test. Continuous variables such as age and length of stay (LOS) are presented as median (interquartile range [IQR]) and compared using Mann–Whitney test based on the normality of the distribution. A comparison was also made among the six most common complications associated with colpocleisis, namely requiring transfusion, hemorrhage, cardiovascular complications, acute renal failure, genitourinary complications, and accidental organ puncture, as well as for any complications. We also examined age distribution among women who underwent colpocleisis with and without complications. Finally, multivariate logistic regression analysis was conducted to estimate odds ratio (OR) and 95% confidence intervals (CI) for the risk of any complications among women undergoing colpocleisis with or without concomitant hysterectomy. Analysis was adjusted for age, race, income, insurance plan, and comorbidities of smoking, obesity, hypertension, diabetes mellitus, chronic obstructive pulmonary disease, coronary artery disease, and chronic kidney disease. After comparing colpocleisis without hysterectomy (reference group) with colpocleisis with concomitant hysterectomy, a second analysis was performed using LeFort colpocleisis as our reference compared with complete colpocleisis for vault prolapse, and with hysterectomy and complete colpocleisis. Statistical significance was set at p<0.05 and all analyses were performed using SPSS for Windows, version 27.0 (IBM Corp.). As data were anonymized and publicly available, institutional review board approval was not required. As per HCUP-NIS policy, results with less than 20 individuals in a group (which represents 0.3% of our sample of colpocleisis cases) could not be reported.
Results
After excluding women with urogenital and gastrointestinal cancers, a total of 253,100 adult women underwent POP repair. Among them, 7,431 women specifically had colpocleisis/colpectomy, whereas the remaining underwent other types of prolapse surgery. 1,656 (22.2%) women had colpocleisis with hysterectomy. Of the 5,775 (77.7%) women without hysterectomy, 2,162 (29.1%) had undergone LeFort colpocleisis and 2,469 (33.2%) had complete colpocleisis for vault prolapse after a remote hysterectomy (Fig. 1). Of individuals with uterine prolapse who underwent colpocleisis, 43.4% underwent a concomitant hysterectomy. The diagnosis (uterine vs vault POP) for the rest of women who underwent colpocleisis without hysterectomy was not clarified in the database (N=1,144). Figure 2 shows that hysterectomy rates among women with POP undergoing colpocleisis remain relatively steady, whereas those undergoing colpocleisis without hysterectomy are declining from 2004 to 2014, going from 12.5 to 9.7 per 100,000. Examining trends for women without concomitant hysterectomy who had either uterine prolapse or vaginal vault prolapse show declining rates across the same timeframe (Supplementary Fig. 1).
Based on sociodemographic variables (Table 1), women undergoing colpocleisis were predominantly older than 71 years old, of white race, and had mostly Medicare insurance. Median (IQR) LOS was shorter for women undergoing colpocleisis than those undergoing any POP repairs (1 [1–2] vs 2 [1–2] days). Alternatively, concomitant hysterectomy increased LOS at the time of colpocleisis compared with those without (2 [1–3] vs 1 [1–2] days; p<0.001). Hypertension was significantly more common among women who underwent colpocleisis without hysterectomy compared to those with concomitant hysterectomy, whereas the rate of hypertension was much lower overall among all women undergoing POP repair. Demographic and baseline characteristics of women undergoing LeFort colpocleisis for uterine prolapse vs complete colpocleisis for vault prolapse were similar (Supplementary Table 1).
Table 2 highlights common perioperative complications among women who underwent colpocleisis with or without concomitant hysterectomy. Concomitant hysterectomy at the time of colpocleisis was associated with an increased risk of complication (11.4 vs 9.5%, p=0.023). Need for blood transfusion was the most common complication, occurring in 281 (3.8%) after colpocleisis. Based on HCUP guidelines of individual cells of less than 20 subjects, details of complications other than the six most common (including death) could not be further analyzed individually. Among women undergoing colpocleisis, those who experienced any complications were marginally older (79 [73–84] vs 78 [72–83], p<0.001). This was especially true for women who had hemorrhage or who required transfusion.
Among 245,669 women who underwent other types of POP repair, 4,310 (1.8%) women experienced gastrointestinal injury, cystotomy or accidental organ puncture, followed by 3,892 (1.6%) women needing blood transfusion. Overall, 15,865 (6.5%) women experienced any of the complications listed (Supplementary Table 2). When we examined age distribution, it was noted that overall, complications occurred among women between 50 and 75 years of age. Hemorrhage occurred at a younger age (53 [43–76], p<0.001). Women who experienced pelvic/peritoneal abscess/hematoma or peritonitis were also found to have it at a younger age (53 [43–76], p=0.001). Very few women died perioperatively. Overall complication rate was higher after colpocleisis than after other POP repairs (9.6% vs 6.5%, p<0.001).
Table 3 describes multivariate logistic regression analysis among colpocleisis patients with and without concomitant hysterectomy and the presence of complications. Upon adjusting for sociodemographic variables, keeping women without hysterectomy as our reference, the odds ratio for women with concomitant hysterectomy for developing any complications was 1.927 (1.445–2.568, p<0.001). When LeFort colpocleisis is the reference group, risk of having any complications among those with complete colpocleisis was not significant (OR 0.945, 95% CI 0,641–1.370,pN=0.764), whereas the risk in those with concomitant hysterectomy was significant (OR 1.666, 1.145–2.425, p=0.008).
Discussion
In this large USA-based database, we found that concomitant hysterectomy was performed in 22% of colpocleisis procedures. Specifically, among women with uterine prolapse, 43.4% underwent a concomitant hysterectomy. Overall perioperative complications occurred in 9.6% of cases, with an increased risk associated with concomitant hysterectomy. Rate of colpocleisis without hysterectomy decreased over time. We reported the respective proportions of colpocleisis that are performed for vault prolapse (39.3%) vs cases of uterine prolapse (60.7%).
We found that patients undergoing colpocleisis without concomitant hysterectomy were older than those undergoing concomitant hysterectomy (median age 78 [73–83] vs 75 [69–80]). This finding is consistent with previous literature. A NSQIP database study of over 1,000 cases showed that mean age at the time of LeFort colpocleisis was 79.4 ± 6.9 years vs 76.7 ± 6.6 years at the time of colpocleisis with concomitant vaginal hysterectomy [3]. Older age was also associated with the risk of any complication in our study (p<0.001). This is consistent with a study by Sung et al. of 264,340 women undergoing urogynecological surgery, although not specific to colpocleisis. In that study, age over 80 was associated with an increased risk of perioperative complications (OR 1.4 [95% CI 1.3–1.5]) and a drastic increased risk of mortality (OR 13.6 [95% CI 5.9–31.4]) compared with women less than 60 years old [11]. Reassuringly, a study of over 100 octogenarians undergoing colpocleisis found a low rate of serious complications (3.2%) despite an overall high complication rate (28.6%) in that older population [12]. In Sung et al, a lower risk of complication was observed for those undergoing obliterative procedures (17.0%) compared with reconstructive procedures (24.7%) [11]. In our study, the rate of complication was comparatively higher after colpocleisis with or without hysterectomy than after other prolapse repair procedures (9.6% vs 6.5%, p<0.001). Although obliterative procedures are often considered less invasive than reconstructive procedures, the increased rate of complications in our study may be related to the higher rate of comorbidities among individuals undergoing colpocleisis compared with those undergoing other prolapse repairs.
In general, it is recommended that concomitant hysterectomy be performed at the time of colpocleisis only in cases of abnormal postmenopausal bleeding or in patients with risk factors for endometrial/cervical cancer [10, 13]. With an overall lifetime incidence of endometrial cancer of 3.1% (NIH data 2022), a concomitant finding of endometrial malignancy in hysterectomy specimens at the time of POP repair or colpocleisis is very rare (0.24–0.5%) [14,15,16,17]. Risk increases with a history of postmenopausal bleeding. A decision analysis model showed that colpocleisis alone has the optimal expected overall utility in women 40–90 years old, this being increasingly true with advancing age [13]. However, multiple patient-related factors may play a role in the decision to undergo concomitant hysterectomy. The recently published Value of Uterus Instrument (VALUS) may be considered to better understand patient preferences, when discussing the role of hysterectomy at the time of prolapse repair [18]. In our study, the use of a large database did not provide information regarding the reason for performing concomitant hysterectomy. Additionally, we excluded malignancy to ensure reporting of complication rates among benign POP cases.
We found a 2.3% increase in the risk of complications associated with hysterectomy at the time of colpocleisis, and an overall low risk of complications of 9.6%. Previous studies had reported larger difference in risk between those groups. Up to 35% required a transfusion with concomitant hysterectomy compared with 13% without hysterectomy in a small study by Von Pechmann et al. [9]. In our large sample, transfusion rate was much lower at 3.5% without hysterectomy and 5.3% with hysterectomy. Serious medical complications were associated with concomitant hysterectomy in the NSQIP study of Bochenska et al. (3.7 vs 0.8%) [3]. Multiple studies unsurprisingly reported longer operating room time with concomitant hysterectomy, which was not addressed in our sample [3, 4, 9, 19].
Reassuringly, we found a very low mortality rate, below 0.3%. Previous literature had reported similar or higher rates in smaller studies, likely related to a longer patient follow-up. For LeFort colpocleisis specifically, an NSQIP surgical complications database of 283 patients found 0.35% mortality [20]. A higher mortality rate of 1.3% was reported by Zebede et al. in a retrospective case series of 325 patients, where the average age was higher (81 years old) [7].
The main strength of our study is its large sample size. To our knowledge, this is the largest reported study of colpocleisis procedures. The high number of cases allowed us to determine the comparative risk of improbable complications between women who had a concomitant hysterectomy and those who did not. We also reported trends of concomitant hysterectomy rates over time. Limitations of this study are intrinsically related to the use of a cross-sectional public health care database. Coding deficiencies limited our interpretation of the results, as 15% of procedures did not have a specific associated diagnosis (uterine vs vault prolapse). The HCUP-NIS database is the largest inpatient sample database in the USA, which limited our search to inpatient cases. Pre-COVID-19 pandemic, most colpocleisis cases were performed as inpatient procedures, as is the case in our data set (including up to 2014) [3, 6]. Since the pandemic started, many pelvic floor surgeries were increasingly being performed with same-day discharge [21, 22]. Readmission and complication rates appear similar after pelvic reconstructive surgeries with same-day discharge, but future studies should be performed among older women undergoing colpocleisis. Those with significant comorbidities may not be amenable to such an approach. In addition, only data from admission to discharge without a link to future emergency visits or readmissions was available in the NIS database. Hence, we could not account for complications occurring after the surgical admission. In a previous large study, hospital readmission was estimated at 3% [6]. On another note, previous literature demonstrated a possible impact of surgeon specialty (urology, gynecology, urogynecology) and center volume on complication rates [20]. These variables were not assessed in our data. Nor did we assess the role of concomitant incontinence procedures. However, a previous study of 283 women undergoing LeFort colpocleisis found no difference in perioperative complications with concomitant sling [20].
Conclusions
We found an overall perioperative complication rate of 9.6% during surgical admission for colpocleisis. Concomitant hysterectomy was associated with an increased risk. Women undergoing these procedures were generally older and had more comorbidities than women undergoing reconstructive pelvic floor surgeries. Shared decision-making regarding concomitant hysterectomy at the time of colpocleisis should be explored and studied further, taking into account individual patients’ values, comorbidities, future risk of endometrial cancer, and respective complication rates.
References
Fitzgerald MP, Richter HE, Siddique S, Thompson P, Zyczynski H, Weber A, for the Pelvic Floor Disorders Network. Colpocleisis: a review. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17(3):261–71.
Fitzgerald MP, Richter HE, Bradley CS, Ye W, Visco AC, Cundiff GW, et al. Pelvic support, pelvic symptoms, and patient satisfaction after colpocleisis. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(12):1603–9.
Bochenska K, Leader-Cramer A, Mueller M, Dave B, Alverdy A, Kenton K. Perioperative complications following colpocleisis with and without concomitant vaginal hysterectomy. Int Urogynecol J. 2017;28(11):1671–5.
Hill AJ, Walters MD, Unger CA. Perioperative adverse events associated with colpocleisis for uterovaginal and posthysterectomy vaginal vault prolapse. Am J Obstet Gynecol. 2016;214(4):501.e1–6.
Koski ME, Chow D, Bedestani A, Togami JM, Chesson RR, Winters JC. Colpocleisis for advanced pelvic organ prolapse. Urology. 2012;80(3):542–6.
Mueller MG, Ellimootil C, Abernethy MG, Mueller ER, Hohmann S, Kenton K. Colpocleisis: a safe, minimally invasive option for pelvic organ prolapse. Female Pelvic Med Reconstr Surg. 2015;21(1):30–3.
Zebede S, Smith AL, Plowright LN, Hegde A, Aguilar VC, Davila GW. Obliterative LeFort colpocleisis in a large group of elderly women. Obstet Gynecol. 2013;121(2 Pt 1):279–84.
Wang X, Chen Y, Hua K. Pelvic symptoms, body image, and regret after LeFort colpocleisis: a long-term follow-up. J Minim Invasive Gynecol. 2017;24(3):415–9.
Von Pechmann WS, Mutone M, Fyffe J, Hale DS. Total colpocleisis with high levator plication for the treatment of advanced pelvic organ prolapse. Am J Obstet Gynecol. 2003;189(1):121–6.
Buchsbaum GM, Lee TG. Vaginal obliterative procedures for pelvic organ prolapse: a systematic review. Obstet Gynecol Surv. 2017;72(3):175–83.
Sung VW, Weitzen S, Sokol ER, Rardin CR, Myers DL. Effect of patient age on increasing morbidity and mortality following urogynecologic surgery. Am J Obstet Gynecol. 2006;194(5):1411–7.
Sifuentes R, Wolff BJ, Barnes HC, Wozniak A, Mueller ER, Pham TT. You're how old? Correlating perioperative complication risk in octogenarians undergoing colpocleisis for pelvic organ prolapse. Female Pelvic Med Reconstr Surg. 2021;27(4):238–43.
Jones KA, Zhuo Y, Solak S, Harmanli O. Hysterectomy at the time of colpocleisis: a decision analysis. Int Urogynecol J. 2016;27(5):805–10.
Hanson GE, Keettel WC. The Neugebauer-Le Fort operation. A review of 288 colpocleises. Obstet Gynecol. 1969;34(3):352–7.
Ackenbom MF, Giugale LE, Wang Y, Shepherd JP. Incidence of occult uterine pathology in women undergoing hysterectomy with pelvic organ prolapse repair. Female Pelvic Med Reconstr Surg. 2016;22(5):332–5.
Vallabh-Patel V, Saiz C, Salamon C, Francis A, Pagnillo J, Culligan P. Prevalence of occult malignancy within morcellated specimens removed during laparoscopic sacrocolpopexy. Female Pelvic Med Reconstr Surg. 2016;22(4):190–3.
Frick AC, Walters MD, Larkin KS, Barber MD. Risk of unanticipated abnormal gynecologic pathology at the time of hysterectomy for uterovaginal prolapse. Am J Obstet Gynecol. 2010;202(5):507.e1-4. https://doi.org/10.1016/j.ajog.2010.01.077.
Chang OH, Walters MD, Yao M, Lapin B. Development and validation of the Value of Uterus instrument and visual analog scale to measure patients' valuation of their uterus. Am J Obstet Gynecol. 2022. https://doi.org/10.1016/j.ajog.2022.06.029.
Hoffman MS, Cardosi RJ, Lockhart J, Hall DC, Murphy SJ. Vaginectomy with pelvic herniorrhaphy for prolapse. Am J Obstet Gynecol. 2003;189(2):364–70 discussion 70–1.
Catanzarite T, Rambachan A, Mueller MG, Pilecki MA, Kim JY, Kenton K. Risk factors for 30-day perioperative complications after Le Fort colpocleisis. J Urol. 2014;192(3):788–92.
Abaza R, Kogan P, Martinez O. Impact of the COVID-19 crisis on same-day discharge after robotic urologic surgery. Urology. 2021;149:40–5.
Hickman LC, Paraiso MFR, Goldman HB, Propst K, Ferrando CA. Same-day discharge after minimally invasive sacrocolpopexy is feasible, safe, and associated with high patient satisfaction. Female Pelvic Med Reconstr Surg. 2021;27(8):e614–9. https://doi.org/10.1097/SPV.0000000000000998.
Funding
The McGill Department of Obstetrics and Gynecology funded the purchase of the HCUP-NIS database used for this study.
Author information
Authors and Affiliations
Contributions
J. Raina: protocol development, database management, data analysis, manuscript writing; M.P. Bastrash: literature review, manuscript writing; E. Suarthana: protocol development, data analysis, manuscript writing; M. Larouche: concept and protocol development, manuscript writing.
Corresponding author
Ethics declarations
Conflicts of interest
M. Larouche reports a research stipend from the St. Mary’s Research Centre.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Table 1
Characteristics of women with uterine prolapse or vault prolapse who underwent colpocleisis without concomitant hysterectomy (DOCX 14 kb)
Supplementary Table 2
Perioperative complications among women who underwent other types of prolapse repair (DOCX 13 kb)
Supplementary Fig. 1
Trend in the prevalence of women with uterine prolapse or vaginal vault prolapse who underwent colpocleisis without concomitant hysterectomy in the USA, 2004–2014 (PDF 78 kb)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Raina, J., Bastrash, MP., Suarthana, E. et al. Perioperative complication rates of colpocleisis performed with or without concomitant hysterectomy: a large population-based study. Int Urogynecol J 34, 1111–1118 (2023). https://doi.org/10.1007/s00192-023-05457-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-023-05457-w